Combination of ibrutinib and chemotherapy produced a durable remission in multiply relapsed diffuse large B-cell lymphoma leg type with mutant MYD88 and wildtype CD79

Andrew L. Deng; Yu Ri Kim; Emily A. Lichtenstein; Owen A. O’Connor; Changchun Deng

doi:10.3324/haematol.2016.161893

YUHSpace

BROWSE

341 464

Cited 0 times in

Cited 12 times in

Combination of ibrutinib and chemotherapy produced a durable remission in multiply relapsed diffuse large B-cell lymphoma leg type with mutant MYD88 and wildtype CD79

Authors: Andrew L. Deng ; Yu Ri Kim ; Emily A. Lichtenstein ; Owen A. O’Connor ; Changchun Deng

Citation: HAEMATOLOGICA, Vol.102(7) : e275-e277, 2017

Journal Title: HAEMATOLOGICA

ISSN: 0390-6078

Issue Date: 2017

Files in This Item:: T201702619.pdf Download

DOI: 10.3324/haematol.2016.161893

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

Yonsei Authors: Kim, Yu Ri(김유리) https://orcid.org/0000-0001-5505-0142

URI: https://ir.ymlib.yonsei.ac.kr/handle/22282913/160558

사서에게 알리기

Show full item record Find it @ YMLIB

License

YUHSpace: Combination of ibrutinib and chemotherapy produced a durable remission in multiply relapsed diffuse large B-cell lymphoma leg type with mutant MYD88 and wildtype CD79

YUHSpace

BROWSE

Browse

Links